Hydrocortisone Hualan (Hydrocortisone)

Hydrocortisone Hualan is prescribed for several endocrine and inflammatory disorders where glucocorticoid activity is required.

• Replacement therapy for primary or secondary adrenal insufficiency, including Addison's disease.
• Management of congenital adrenal hyperplasia to suppress excess androgen production.
• Control of acute or chronic inflammatory conditions such as rheumatoid arthritis, severe dermatitis, or asthma exacerbations.
• Adjunctive treatment in certain autoimmune disorders where immune modulation is needed.
• Short‑term use for stress dosing during major surgery or severe illness in patients with known cortisol deficiency.

• Hydrocortisone Hualan acts as an agonist at intracellular glucocorticoid receptors, forming a hormone‑receptor complex that translocates to the nucleus and binds glucocorticoid response elements on DNA. This interaction alters transcription of multiple genes, leading to decreased synthesis of pro‑inflammatory cytokines, inhibition of leukocyte migration, and suppression of immune cell activation, thereby providing anti‑inflammatory and immunosuppressive effects while also replacing deficient endogenous cortisol.

Adverse reactions to hydrocortisone may vary in frequency and severity.

Common

• Mild gastrointestinal discomfort or nausea.
• Transient increase in blood glucose levels.
• Fluid retention causing mild edema.
• Mood changes such as irritability or mild anxiety.
• Skin thinning or easy bruising with prolonged use.

Serious

• Severe hyperglycemia or new‑onset diabetes mellitus.
• Significant hypertension or cardiovascular events.
• Opportunistic infections due to immunosuppression.
• Osteoporosis or pathological fractures with long‑term therapy.
• Adrenal crisis on abrupt discontinuation after prolonged use.

Before initiating Hydrocortisone Hualan, clinicians should evaluate several safety considerations.

• Assess for active infections; glucocorticoids can worsen bacterial, viral, or fungal illnesses.
• Screen for uncontrolled diabetes, hypertension, or cardiovascular disease, as the drug may exacerbate these conditions.
• Use the lowest effective dose for the shortest duration to reduce risk of bone loss and cataract formation.
• Taper gradually after long‑term therapy to avoid adrenal insufficiency.
• Counsel pregnant or breastfeeding patients that safety data are limited and benefits must outweigh potential risks.
• Monitor electrolyte balance, especially potassium, in patients receiving high doses or concomitant diuretics.

Hydrocortisone Hualan can affect, or be affected by, several other medications.

Avoid

• Strong CYP3A4 inducers such as rifampin or phenytoin, which may reduce hydrocortisone plasma concentrations.
• Live vaccines, because immunosuppression can increase the risk of vaccine‑derived infection.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) at high doses, which together may raise the risk of gastrointestinal bleeding.

Use with caution

• Antidiabetic agents, as hydrocortisone may raise blood glucose and require dose adjustments.
• Antihypertensive drugs, particularly ACE inhibitors or diuretics, because fluid retention can blunt their effect.
• Anticoagulants, since glucocorticoids can alter platelet function and affect INR levels.
• Other systemic steroids, to avoid cumulative glucocorticoid exposure and heightened adverse‑event risk.